Thomas Sené

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 291 citations · Full text

Life Sciences, Immunology, Internal Medicine +14

Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial

Aurélien Dinh, Jacques Ropers, Clara Duran et al. · The Lancet · 2021 · 162 citations

Pharmacy, Pharmacotherapy, Antimicrobial Pharmacotherapy +13

High prevalence of myeloid neoplasms in adults with non–Langerhans cell histiocytosis

Matthias Papo, Eli L. Diamond, Fleur Cohen‐Aubart et al. · Blood · 2017 · 147 citations · Full text

Veterinary Medicine, Oncology, Pathology +13

Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no‐treatment study

Michaël Loschi, Raphaël Porcher, Fiorenza Barraco et al. · American Journal of Hematology · 2015 · 141 citations · Full text

Medicine, Hematology, Clinical Pharmacology +7

Anti–Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema

Mathilde Leclercq, Anaïs Andrillon, Georgina Maalouf et al. · Ophthalmology · 2021 · 76 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +12